Burkitt Lymphoma
Showing 4651 - 4675 of 5,429
Previously Treated CD20+ B-cell Malignancies Trial in Dallas (ocaratuzumab)
Unknown status
- Previously Treated CD20+ B-cell Malignancies
- ocaratuzumab
-
Dallas, TexasUniverstity of Texas Southwestern Medical Center
Feb 28, 2014
HIV Trial in United States (tenofovir DF 300 mg QD, emtricitabine 200 mg QD, Nevirapine 200 mg BID)
Completed
- HIV Infections
- tenofovir DF 300 mg QD
- +4 more
-
Beverly Hills, California
- +18 more
Dec 9, 2013
Lymphoma Trial in Canada, United States (autologous immunoglobulin idiotype-KLH conjugate vaccine, keyhole limpet hemocyanin,
Unknown status
- Lymphoma
- autologous immunoglobulin idiotype-KLH conjugate vaccine
- +5 more
-
Dublin, California
- +23 more
Dec 3, 2013
Lymphoma, Low-Grade Trial in Japan (Fludarabine Phosphate (Fludara), Rituximab)
Completed
- Lymphoma, Low-Grade
- Fludarabine Phosphate (Fludara)
- Rituximab
-
Nagoya-shi, Aichi, Japan
- +7 more
Dec 2, 2013
Non-Hodgkin's Lymphoma Trial in Tampa (LBH589)
Terminated
- Non-Hodgkin's Lymphoma
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Nov 21, 2013
Lymphoma Trial in Rockville (beta alethine)
Unknown status
- Lymphoma
- beta alethine
-
Rockville, MarylandVictory Over Cancer
Dec 17, 2013
Lymphoma Trial in Los Angeles (epratuzumab)
Unknown status
- Lymphoma
- epratuzumab
-
Los Angeles, CaliforniaJonsson Comprehensive Cancer Center, UCLA
Dec 18, 2013
Aplastic Anemia, Paroxysmal Nocturnal Hemoglobinuria, Acute Myelogenous Leukemia Trial in La Jolla (Nonmyeloablative Allogeneic
Unknown status
- Aplastic Anemia
- +17 more
- Nonmyeloablative Allogeneic Transplant
-
La Jolla, CaliforniaScripps Green Hospital
Dec 5, 2013
Chemotherapeutic Agent Toxicity, Lymphoma, Mucositis Trial in Leeds, Torquay (drug, other, procedure, radiation)
Completed
- Chemotherapeutic Agent Toxicity
- +3 more
- glucarpidase
- +5 more
-
Leeds, England, United Kingdom
- +1 more
Jan 24, 2014
Lymphoma Trial in Houston (bryostatin 1, chemo)
Completed
- Lymphoma
- bryostatin 1
- chemotherapy
-
Houston, TexasUniversity of Texas - MD Anderson Cancer Center
Feb 4, 2013
Lymphoma Trial in Freemont (apolizumab)
Unknown status
- Lymphoma
- apolizumab
-
Freemont, CaliforniaProtein Design Labs, Inc.
Dec 17, 2013
Lymphoma Trial in Worldwide (biological, drug, radiation)
Completed
- Lymphoma
- rituximab
- +5 more
-
Birmingham, Alabama
- +86 more
Jan 27, 2014
Lymphoma Trial in Birmingham, Stanford, Rochester (rituximab, yttrium Y 90 ibritumomab tiuxetan)
Terminated
- Lymphoma
- rituximab
- yttrium Y 90 ibritumomab tiuxetan
-
Birmingham, Alabama
- +2 more
Dec 12, 2013
EBV Associated Lymphoma Trial in France (Injection of allogenic CTL EBV specific)
Unknown status
- EBV Associated Lymphoma
- Injection of allogenic CTL EBV specific
-
Bordeaux, France
- +6 more
Nov 14, 2013
Lymphoma Trial in Los Angeles (epratuzumab)
Unknown status
- Lymphoma
- epratuzumab
-
Los Angeles, CaliforniaJonsson Comprehensive Cancer Center, UCLA
Dec 18, 2013
Chronic Myeloproliferative Disorders, Infection, Leukemia Trial (Edetate Calcium Disodium, Ethanol,
Withdrawn
- Chronic Myeloproliferative Disorders
- +8 more
- Edetate Calcium Disodium
- +3 more
- (no location specified)
Feb 13, 2013
Solid Tumors, Lymphoma Trial in Scottsdale, Columbus, Sutton (AR-12: (2-Amino-N-[4-[5-(2
Completed
- Solid Tumors
- Lymphoma
- AR-12: (2-Amino-N-[4-[5-(2 phenanthrenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl] phenyl]-acetamide)
-
Scottsdale, Arizona
- +2 more
Jan 28, 2014
Lymphoma, Multiple Myeloma and Plasma Cell Tumor Trial in Duarte, Pasadena (everolimus, panobinostat, laboratory biomarker
Completed
- Lymphoma
- Multiple Myeloma and Plasma Cell Neoplasm
- everolimus
- +3 more
-
Duarte, California
- +1 more
Feb 13, 2013
Lymphoma Trial in United States (apolizumab)
Completed
- Lymphoma
- apolizumab
-
Washington, District of Columbia
- +4 more
Feb 8, 2013
Lymphoma, Follicular Trial in Puerto Rico, United States (Sargramostim (Leukine), Rituximab)
Terminated
- Lymphoma, Follicular
- Sargramostim (Leukine)
- Rituximab
-
Birmingham, Alabama
- +21 more
Dec 2, 2013
Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Chicago (tipifarnib)
Completed
- Chronic Myeloproliferative Disorders
- +4 more
-
Chicago, IllinoisUniversity of Chicago Cancer Research Center
Feb 8, 2013
Brain and CNS Tumors, Chronic Myeloproliferative Disorders, Leukemia Trial in Seoul (donor natural killer cell infusion)
Completed
- Brain and Central Nervous System Tumors
- +8 more
- donor natural killer cell infusion
-
Seoul, Korea, Republic ofUniversity of Ulsan, Asan Medical Center
Feb 18, 2013